MENU
RDY
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Dr. Reddy's Laboratories (RDY) Ownership - Who owns Dr. Reddy's Laboratories?
Dr... Show more
Industry: #Pharmaceuticals Generic
Profile
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
12.48B
P/E Ratio
19.68
Total Cash
72.36B
Projected Growth
4.88
Total Debt
19.85B
Revenue
271.3B
Risk (Beta)
0.51
Dividend Yield
0.01
Total Cash/Share
434.52
Total Debt/Equity
49.28
Revenue/Share
19.53 USD as % of share price
Fundamentals
RDY
Capitalization
12.5B
P/E Ratio
19.68
Risk (Beta)
0.51
Dividend Yield
0.01
Total Cash
72.4B
Total Cash/Share
434.52
Total Debt
19.9B
Total Debt/Equity
49.28
Projected Growth (PEG Ratio)
4.88
Revenue/Share (as % of the share price)
19.53%
Revenue
271B
ROE
N/A
Book Value
268B
P/B Ratio
3.83
Cash Flow
N/A
Earnings
313.91
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
834M
Current Ratio
2.55
Current Revenue Per Employee
3161335.50
Dividends Per Share - Security
0.00
EBITDA
84.9B
Float
N/A
Float - Current
N/A
Gross Income Margin
58.49
Revenue To Assets
15.31
Shares Held By Institutions
4.78B
Shares Outstanding - Current
167M
Total Liabilities
105B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-13.331
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RDY showed earnings on July 23, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com